SCHEMBL27760976

SCHEMBL27760976

COc1cccc(C(C)CC(O)(C=O)C(F)(F)F)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 6/20 0.35
NR3C2 P08235 5/20 0.35
PGR P06401 2/20 0.35
LPAR1 Q92633 1/20 0.34
CYP19A1 P11511 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
KCNK3 O14649 1/20 0.33
KCNK9 Q9NPC2 1/20 0.33
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 2/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
PDK1 Q15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260079 0.89 PDK1 (0.38) NR3C1NR3C2LPAR1L3MBTL1HPGD
SCHEMBL3540058 0.86 ERN1 (0.35) NR3C1NR3C2PGRL3MBTL1HPGD
SCHEMBL27782520 0.86 P2RX7 (0.34) NR3C1NR3C2PGRCYP19A1L3MBTL1
SCHEMBL1261398 0.83 HSD11B1 (0.33) NR3C1NR3C2PGRSMN1; SMN2KMT2A
SCHEMBL5774836 0.81 NR3C1 (0.43) NR3C1NR3C2PGR
SCHEMBL3745087 0.79 CTSS (0.32) MEN1CYP3A4KMT2A
SCHEMBL1261086 0.79 CTSS (0.32) MEN1CYP3A4KMT2A
SCHEMBL3751137 0.79 CTSS (0.32) MEN1CYP3A4KMT2A
SCHEMBL27650704 0.77 NR3C1 (0.45) NR3C1NR3C2PGRCYP19A1
SCHEMBL1260203 0.76 L3MBTL1 (0.42) L3MBTL1HPGDSMN1; SMN2NPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101553472-A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents BAYER SCHERING PHARMA AG (DE) 2009-10-07 CN disclosed